# BPC-157 Troches (Sublingual)

> BPC-157 in sublingual troche form — 500 mcg per troche

All products are sold strictly for laboratory research use only. Not for human or veterinary use.

- Web page: https://peptidemedixeu.com/en/products/bpc-157-troches/
- Brand: Peptide Medix EU
- Category: [Gut Health Peptides](https://peptidemedixeu.com/en/collections/gut-health-peptides/)
- Purity: ≥99% by HPLC before compounding; lot-matched COA available
- from €76 (EUR)

## Sizes and prices (EUR)

| Size | Price | SKU |
| --- | --- | --- |
| 500 mcg · 30 troches | €76 | BPC-157-TROCHES-500-MCG-30-TROCHES |

_Catalog prices at build time; the web page and checkout are authoritative._

## Specifications

- **Form:** Sublingual troche in a slowly dissolving compounding base
- **Peptide content:** 500 mcg BPC-157 per troche
- **Available size:** 30 troches per pack
- **Active component:** BPC-157, synthetic gastric pentadecapeptide
- **Amino acid sequence (active):** Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- **CAS number (active):** 137525-51-0
- **Molecular formula (active):** C62H98N16O22
- **Molecular weight (active):** 1419.55 g/mol
- **Peptide purity:** ≥99% by HPLC before compounding; lot-matched COA available
- **Delivery route studied:** Sublingual and buccal mucosal absorption
- **Research areas:** Gastrointestinal mucosal integrity, barrier function, transmucosal peptide delivery, formulation stability
- **Preparation required:** None — fixed unit content, no reconstitution or dilution step
- **Storage:** Cool, dry and dark in the closed pack; refrigeration extends shelf stability

## Description

This product delivers BPC-157 in a slow-dissolving sublingual base instead of as lyophilised powder that needs reconstitution. Each troche contains 500 micrograms of the pentadecapeptide, and a pack contains thirty. The peptide is the same as in our vials and capsules: the 15-residue sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a partial fragment of body protection compound from human gastric juice, produced by solid-phase synthesis and HPLC-purified to ≥99%.

BPC-157 lends itself unusually well to transmucosal research because of its exceptional stability for a peptide of this size. The parent protein originates in the stomach, and stability studies report that the fragment withstands acidic aqueous conditions that would quickly break down most peptides. That is exactly why the literature covers oral, intragastric and now transmucosal routes, not just injection.

## Frequently asked questions

### What distinguishes the troches from BPC-157 capsules?

Both provide fixed 500 mcg units of the identical peptide, but they release it in different places. A capsule empties into the gastrointestinal tract, while a troche dissolves on the oral mucosa, allowing part of the peptide to pass that epithelium directly and avoid first-pass metabolism in the liver.

### Is it the same peptide as the powder in the vials?

Yes. Our vials, capsules and troches all use the same HPLC-purified, solid-phase synthesised BPC-157. Only the delivery format varies, which allows matched comparisons between formats without introducing a second material variable.

### What proportion of the peptide crosses the mucosa?

No published constant exists — finding out is the point of the research. Peptides of this molecular weight usually permeate the mucosa only modestly, and troche studies are set up specifically to measure that fraction under defined formulation conditions.

### Which purity documents are available?

The peptide used in production is released at ≥99% purity by reversed-phase HPLC, and the lot's certificate of analysis can be requested. Filing it with your records links the compounded troches to the exact peptide lot inside them.

### Why is temperature control stressed?

Heat softens troche bases and they absorb humidity from the air, which deforms them and speeds up peptide breakdown. Storing the closed pack cool, dry and dark preserves both the physical form and the peptide content for the planned period of use.

---

All products offered on this website are intended solely for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics or dietary supplements, and are not intended to diagnose, treat, cure or prevent any disease. Products must not be introduced into humans or animals in any manner. By purchasing, you confirm that you are a qualified researcher and accept full responsibility for handling and storage in accordance with applicable laws.

Peptide Medix EU · https://peptidemedixeu.com/en/products/bpc-157-troches/